European Horizon Europe Program Allocates 7.4 Million Euros for Marburg Virus Vaccine Research and Development – MARVAX Consortium Receives Funding from EU
The European multidisciplinary consortium MARVAXin which the Higher Council for Scientific Research participates (CSIC) and the Spanish pharmaceutical company CZ Vaccinesof the Group Zendalwill receive from the Horizon Europe program 7.4 million euros over the next four years for research and development of Marburg virus vaccinesa pathogen zoonosic from the same family as the Ebola … Read more